MetLife Expands Usage-Based Auto Insurance Program with New App to Help Drivers Stay Safer and Lower Their Rates
The My Journey program app automatically tracks key driving behaviors, including total miles driven, time of day, road type and conditions, hard braking and harsh acceleration, and phone-based distracted driving, in order to arrive at a score for each trip. The app does so by leveraging the sensors that are built into smartphones to continuously analyze data as the car is in motion. The app calculates and immediately displays an overall score for each trip from 1-100, with 100 being the safest possible trip. A cumulative safety score is built as time goes by.
“Today’s drivers face more distractions on the road than ever, which increases the risk of driving and puts upward pressure on car insurance rates,” noted
Through the app, drivers can get a good idea of how they drive, as well as when and by what they are being distracted, so they can alter their behavior and become safer drivers. Drivers who enroll in the program immediately get ten percent off MetLife Auto & Home’s standard rates. After drivers spend six months in the program, MetLife Auto & Home will have enough driving data calculate a discount , and careful behavior will be rewarded with rates up to 30 percent off at the following renewal. Rates are not being increased as a result of information gathered, and the My Journey mobile app is free to those who enroll in the program.
“Our technology gives MetLife Auto & Home customers feedback that helps them become better drivers and makes the roads safer for all,” said
The smartphone-enabled My Journey program is now available in
About MetLife Auto & Home:
MetLife Auto & Home is one of the nation’s leading personal lines insurance groups, insuring more than 4 million autos and homes, and is affiliated with MetLife. For more information, visit www.metlife.com.
About MetLife
About TrueMotion
Headquartered in
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005689/en/
[email protected]
Source:


FDA’s Pazdur Outlines How Oncology Center of Excellence Will Promote Collaboration in AJMC®’s Evidence-Based Oncology™
Advisor News
- When new investment trends emerge, Gen Z is most likely generation to be first in
- Could ‘plain English’ become an advisor’s secret weapon?
- IRI urges Senate action on 403(b) parity legislation
- Three estate planning ideas to protect your clients and their wealth
- What advisors must know about accessible client documents
More Advisor NewsAnnuity News
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
- Wink: Annuity sales post strong Q2, led by MYGAs and structured products
- Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity NewsHealth/Employee Benefits News
Life Insurance News